Complete inhibition of anisomycin and UV radiation but not cytokine induced JNK and p38 activation by an aryl-substituted dihydropyrrolopyrazole quinoline and mixed lineage kinase 7 small interfering RNA
about
Lung inflammation caused by inhaled toxicants: a reviewActivation of cell stress response pathways by Shiga toxinsIdentification of small molecules that suppress ricin-induced stress-activated signaling pathwaysMarked small molecule libraries: a truncated approach to molecular probe design.Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory responseZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cells.Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms.Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinibPhosphorylation of Atg5 by the Gadd45β-MEKK4-p38 pathway inhibits autophagy.Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin.BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.A Novel Zak Knockout Mouse with a Defective Ribotoxic Stress Response.A Requirement for ZAK Kinase Activity in Canonical TGF-β Signaling.A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles.Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1Targeting kinases for the treatment of inflammatory diseases.Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients.Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model.ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression.Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity.The p38 SAPK is recruited to chromatin via its interaction with transcription factorsA comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.Transient global cerebral ischemia induces up-regulation of MLTKα in hippocampal CA1 neurons.The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.
P2860
Q26744356-E37AF60E-0C15-458F-9018-DA41BD1ABDD4Q27027623-D07823CD-7F95-4778-9379-14968A5893C2Q28484768-A0AB81FE-665F-4F5B-B985-1A9270C67B2DQ33272552-F9C165D9-EA77-465F-A8E5-9236D080D21BQ33426863-1C28B2A9-6D11-4F07-AAA7-4349B120FC62Q33808280-2E42D8BE-D021-4D78-85AB-3CE06B20CDCFQ34581761-2C4F34E4-74A0-4E03-8CF3-3BA4108A9432Q35952061-A1A3A97B-16ED-4199-9465-214F383CEA46Q36382092-FEB1A7C3-EAAF-4540-A59A-4B4C7B0E9B21Q36560485-4AC45DBF-18B3-4D23-9636-1B41B52DBDD8Q36591937-1447C6C2-5207-451F-9527-8221B16CEAF2Q37271732-004240B3-3BA4-48C2-B147-50ED1AD2EF40Q37285664-A61D55F7-EB97-4FF5-B157-4E34E85C87B9Q37367111-C187108E-BB17-498F-9C15-C5AC517B37A3Q37513287-705A4030-68B1-4130-95B5-AEA97DF67E54Q37590508-12D3AFDF-41A8-4F92-9103-247B6C00F3A4Q38028572-8E734636-EBC8-4A10-BF14-0C095D8FF2B8Q38809615-C9267008-6D14-4403-A7EA-AD57CD6C8BA0Q39433444-CCA2767F-C157-461A-9ABC-C5C53CDC2D80Q39584429-4B65DCEF-90F9-47FC-93A4-B973D56D7794Q40003950-A4A05FFB-4DE5-4FB4-B7C8-1A9C3A613223Q42369948-50BCCDAF-498A-470A-8FA8-8D413B73316DQ42413010-4324C237-98DE-4DA7-978E-C4F7F4CC1BE4Q43248374-0124E569-FFC9-4938-9D85-0792DB3FF212Q48795134-F58ABEA4-3187-4587-93B9-E00F45DBE687Q52905418-6F6D26A0-5D7A-4274-AAF9-0E6A6D9506A3
P2860
Complete inhibition of anisomycin and UV radiation but not cytokine induced JNK and p38 activation by an aryl-substituted dihydropyrrolopyrazole quinoline and mixed lineage kinase 7 small interfering RNA
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@ast
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@en
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@nl
type
label
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@ast
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@en
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@nl
prefLabel
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@ast
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@en
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@nl
P2093
P2860
P3181
P356
P1476
Complete inhibition of anisomy ...... kinase 7 small interfering RNA
@en
P2093
Arindam Chatterjee
Chris J Vlahos
Jeffrey K Smallwood
John E Toth
Laura J Bloem
Mary M Mader
Michael E Christe
Robert M Campbell
Theodore Goodson
P2860
P304
P3181
P356
10.1074/JBC.M413059200
P407
P577
2005-05-13T00:00:00Z